Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension of fenfluramine (ZX008) in Dravet syndrome
jRCT2041200095Completed
- Sponsor
- Zogenix, Inc.
- Start
- Nov 2019
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of fenfluramine in Dravet syndrome, sponsored by Zogenix, Inc. Primary endpoint: Long-term safety and tolerability. Started Nov 2019; status: completed.
02
Drugs
fenfluramine
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on jRCT2041200095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041200095.